Sebastian Havervall

About me
Publications
CV
Public outreach and news

About me

* Consultant at Danderyd hospital, Stockholm, Sweden
* Specialist in Internal Medicine and Gastroenterology and Hepatology
* PhD-student in Thålin research group

Articles

Article: FRONTIERS IN IMMUNOLOGY. 2024;15:1346749
Comparison of SARS-CoV-2 spike-specific IgA and IgG in nasal secretions, saliva and serum
Bladh O; Aguilera K; Marking U; Kihlgren M; Norin NG; Smed-Sorensen A; Chen MS; Klingstrom J; Blom K; Russell MW; Havervall S; Thalin C; Aberg M
Article: NATURE COMMUNICATIONS. 2023;14(1):1577
Correlates of protection and viral load trajectories in omicron breakthrough infections in triple vaccinated healthcare workers
Marking U; Havervall S; Norin NG; Bladh O; Christ W; Gordon M; Ng H; Blom K; Phillipson M; Mangsbo S; Alm JJ; Smed-Sorensen A; Nilsson P; Hober S; Aberg M; Klingstroem J; Thalin C
Article: RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS. 2023;7(3):100124
Tissue factor activity of small and large extracellular vesicles in different diseases
Sachetto ATA; Archibald SJ; Hisada Y; Rosell A; Havervall S; van Es N; Nieuwland R; Campbell RA; Middleton EA; Rondina MT; Thalin C; Mackman N
Article: CYTOKINE. 2022;159:156020
IL-6 signalling biomarkers in hospitalised patients with moderate to severe SARS-CoV-2 infection in a single centre study in Sweden
Ziegler L; Lundstrom A; Havervall S; Thalin C; Gigante B
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2022;96(5):e13215
Impact of monocyte-related modulators and kidney function on mortality in hospitalized patients with COVID-19
Sendic S; Mansouri L; Havervall S; Thalin C; Lundahl J; Jacobson SH
Article: BMC NEPHROLOGY. 2022;23(1):299
"Role of kidney function and concentrations of BAFF, sPD-L1 and sCD25 on mortality in hospitalized patients with COVID-19"
Mansouri L; Sendic S; Havervall S; Thalin C; Jacobson SH; Lundahl J
Article: EMBO MOLECULAR MEDICINE. 2022;14(8):e15230
Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variants
Monteil V; Eaton B; Postnikova E; Murphy M; Braunsfeld B; Crozier I; Kricek F; Niederhofer J; Schwarzbock A; Breid H; Devignot S; Klingstrom J; Thalin C; Kellner MJ; Christ W; Havervall S; Mereiter S; Knapp S; Jimenez AS; Bugajska-Schretter A; Dohnal A; Ruf C; Gugenberger R; Hagelkruys A; Montserrat N; Kozieradzki I; Ali OH; Stadlmann J; Holbrook MR; Schmaljohn C; Oostenbrink C; Shoemaker RH; Mirazimi A; Wirnsberger G; Penninger JM
Article: IMMUNITY, INFLAMMATION AND DISEASE. 2022;10(4):e595
Long-term SARS-CoV-2-specific and cross-reactive cellular immune responses correlate with humoral responses, disease severity, and symptomatology
Lauren I; Havervall S; Ng H; Lord M; Pettke A; Greilert-Norin N; Gabrielsson L; Chourlia A; Amoedo-Leite C; Josyula VS; Eltahir M; Kerzeli I; Falk AJ; Hober J; Christ W; Wiberg A; Hedhammar M; Tegel H; Burman J; Xu F; Pin E; Manberg A; Klingstrom J; Christoffersson G; Hober S; Nilsson P; Philipson M; Donnes P; Lindsay R; Thalin C; Mangsbo S
Article: VACCINES. 2022;10(3):359
Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines
Marking U; Havervall S; Greilert-Norin N; Ng H; Blom K; Nilsson P; Phillipson M; Hober S; Nilsson C; Mangsbo S; Christ W; Klingstrom J; Gordon M; Aberg M; Thalin C
Article: NEW BIOTECHNOLOGY. 2022;66:46-52
A cell-free high throughput assay for assessment of SARS-CoV-2 neutralizing antibodies
Mravinacova S; Jonsson M; Christ W; Klingstrom J; Yousef J; Hellstrom C; Hedhammar M; Havervall S; Thalin C; Pin E; Tegel H; Nilsson P; Manberg A; Hober S
Article: PLOS ONE. 2022;17(1):e0262169
SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection
Havervall S; Falk AJ; Klingstrom J; Ng H; Greilert-Norin N; Gabrielsson L; Salomonsson A-C; Isaksson E; Rudberg A-S; Hellstrom C; Andersson E; Olofsson J; Skoglund L; Yousef J; Pin E; Christ W; Olausson M; Hedhammar M; Tegel H; Mangsbo S; Phillipson M; Manberg A; Hober S; Nilsson P; Thalin C
Article: CLINICAL & TRANSLATIONAL IMMUNOLOGY. 2022;11(4):e1388
Impact of SARS-CoV-2 infection on vaccine-induced immune responses over time
Havervall S; Marking U; Greilert-Norin N; Gordon M; Ng H; Christ W; Phillipson M; Nilsson P; Hober S; Blom K; Klingstrom J; Mangsbo S; Aberg M; Thalin C
Article: JOURNAL OF INTERNAL MEDICINE. 2022;291(1):72-80
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19
Havervall S; Ng H; Jernbom Falk A; Greilert-Norin N; Manberg A; Marking U; Lauren I; Gabrielsson L; Salomonsson A-C; Aguilera K; Kihlgren M; Mansson M; Rosell A; Hellstrom C; Andersson E; Olofsson J; Skoglund L; Yousef J; Pin E; Lord M; Aberg M; Hedhammar M; Tegel H; Donnes P; Phillipson M; Nilsson P; Klingstrom J; Mangsbo S; Hober S; Thalin C
Article: JOURNAL OF MEDICAL VIROLOGY. 2021;93(10):5908-5916
Soluble angiotensin-converting enzyme 2 is transiently elevated in COVID-19 and correlates with specific inflammatory and endothelial markers
Lundstrom A; Ziegler L; Havervall S; Rudberg A-S; von Meijenfeldt F; Lisman T; Mackman N; Sanden P; Thalin C
Article: SCIENTIFIC REPORTS. 2021;11(1):18025
Neutrophil extracellular traps in patients with liver cirrhosis and hepatocellular carcinoma
Zenlander R; Havervall S; Magnusson M; Engstrand J; Agren A; Thalin C; Stal P
Article: EBIOMEDICINE. 2021;70:103523
Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2
Havervall S; Marking U; Greilert-Norin N; Ng H; Gordon M; Salomonsson A-C; Hellstrom C; Pin E; Blom K; Mangsbo S; Phillipson M; Klingstrom J; Hober S; Nilsson P; Aberg M; Thalin C
Article: SCIENTIFIC REPORTS. 2021;11(1):14015
An artificial neural network approach integrating plasma proteomics and genetic data identifies PLXNA4 as a new susceptibility locus for pulmonary embolism
Razzaq M; Iglesias MJ; Ibrahim-Kosta M; Goumidi L; Soukarieh O; Proust C; Roux M; Suchon P; Boland A; Daiain D; Olaso R; Havervall S; Thalin C; Butler L; Deleuze J-F; Odeberg J; Morange P-E; Tregouet D-A
Article: NATURE COMMUNICATIONS. 2021;12(1):3695
Multianalyte serology in home-sampled blood enables an unbiased assessment of the immune response against SARS-CoV-2
Roxhed N; Bendes A; Dale M; Mattsson C; Hanke L; Dodig-Crnkovic T; Christian M; Meineke B; Elsasser S; Andrell J; Havervall S; Thalin C; Eklund C; Dillner J; Beck O; Thomas CE; McInerney G; Hong M-G; Murrell B; Fredolini C; Schwenk JM
Article: ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY. 2021;41(2):988-994
Circulating Markers of Neutrophil Extracellular Traps Are of Prognostic Value in Patients With COVID-19
Ng H; Havervall S; Rosell A; Aguilera K; Parv K; von Meijenfeldt FA; Lisman T; Mackman N; Thalin C; Phillipson M
Article: ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY. 2021;41(2):878-882
Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report
Rosell A; Havervall S; von Meijenfeldt F; Hisada Y; Aguilera K; Grover SP; Lisman T; Mackman N; Thalin C
Article: PLOS ONE. 2021;16(9):e0258041
An evaluation of a FluoroSpot assay as a diagnostic tool to determine SARS-CoV-2 specific T cell responses
Mangsbo SM; Havervall S; Lauren I; Lindsay R; Falk AJ; Marking U; Lord M; Buggert M; Donnes P; Christoffersson G; Nilsson P; Hober S; Phillipson M; Klingstrom J; Thalin C
Article: FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY. 2021;11:795026
A Model Predicting Mortality of Hospitalized Covid-19 Patients Four Days After Admission: Development, Internal and Temporal-External Validation
Heber S; Pereyra D; Schrottmaier WC; Kammerer K; Santol J; Rumpf B; Pawelka E; Hanna M; Scholz A; Liu M; Hell A; Heiplik K; Lickefett B; Havervall S; Traugott MT; Neuboeck MJ; Schoergenhofer C; Seitz T; Firbas C; Karolyi M; Weiss G; Jilma B; Thalin C; Bellmann-Weiler R; Salzer HJF; Szepannek G; Fischer MJM; Zoufaly A; Gleiss A; Assinger A
Article: CLINICAL & TRANSLATIONAL IMMUNOLOGY. 2021;10(7):e1312
Systematic evaluation of SARS-CoV-2 antigens enables a highly specific and sensitive multiplex serological COVID-19 assay
Hober S; Hellstrom C; Olofsson J; Andersson E; Bergstrom S; Jernbom Falk A; Bayati S; Mravinacova S; Sjoberg R; Yousef J; Skoglund L; Kanje S; Berling A; Svensson A-S; Jensen G; Enstedt H; Afshari D; Xu LL; Zwahlen M; von Feilitzen K; Hanke L; Murrell B; McInerney G; Karlsson Hedestam GB; Lendel C; Roth RG; Skoog I; Svenungsson E; Olsson T; Fogdell-Hahn A; Lindroth Y; Lundgren M; Maleki KT; Lagerqvist N; Klingstrom J; Da Silva Rodrigues R; Muschiol S; Bogdanovic G; Arroyo Muhr LS; Eklund C; Lagheden C; Dillner J; Sivertsson A; Havervall S; Thalin C; Tegel H; Pin E; Manberg A; Hedhammar M; Nilsson P
Article: RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS. 2021;5(1):132-141
Prothrombotic changes in patients with COVID-19 are associated with disease severity and mortality
von Meijenfeldt FA; Havervall S; Adelmeijer J; Lundstrom A; Rudberg A-S; Magnusson M; Mackman N; Thalin C; Lisman T
Article: NATURE COMMUNICATIONS. 2020;11(1):5064
SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden
Rudberg A-S; Havervall S; Manberg A; Jernbom Falk A; Aguilera K; Ng H; Gabrielsson L; Salomonsson A-C; Hanke L; Murrell B; McInerney G; Olofsson J; Andersson E; Hellstrom C; Bayati S; Bergstrom S; Pin E; Sjoberg R; Tegel H; Hedhammar M; Phillipson M; Nilsson P; Hober S; Thalin C
Show more

All other publications

Thesis / dissertation: 2024
Immune responses after SARS-CoV-2 infection and/or vaccination
Havervall, Sebastian
Letter: THE LANCET REGIONAL HEALTH. EUROPE. 2024;38:100872
Prevalence of SARS-CoV-2 infections among Swedish healthcare workers on duty in December 2023
Aguilera K; Bladh O; Marking U; Norin NG; Rihani A; Ujvari D; Ning FC; Klingstroem J; Havervall S; Aberg M; Blom K; Alm JJ; Thalin C
Letter: THE LANCET INFECTIOUS DISEASES. 2024;24(2):e80-e81
Humoral immune responses to the monovalent XBB.1.5-adapted BNT162b2 mRNA booster in Sweden
Letter: NEW ENGLAND JOURNAL OF MEDICINE. 2023;389(17):1626-1628
Mucosal and Serum Antibodies 3 Weeks after Symptomatic BA.2.86 Infection
Bladh O; Greilert-Norin N; Havervall S; Marking U; Aguilera K; Alm JJ; Blom K; Aberg M; Klingstrom J; Thalin C
Letter: THE LANCET REGIONAL HEALTH. EUROPE. 2023;33:100725
Point prevalence of SARS-CoV-2 infection among healthcare workers in March and June 2023 in Sweden
Blom K; Bladh O; Havervall S; Marking U; Norin NG; Alm JJ; Klingstrom J; Thalin C
Letter: THE LANCET INFECTIOUS DISEASES. 2023;23(8):e272-e273
Mucosal IgA protects against BQ.1 and BQ.1.1 infection
Marking U; Bladh O; Havervall S; Greilert-Norin N; Gordon M; Alm JJ; Blom K; Aberg M; Klingstrom J; Thalin C
Letter: THE LANCET MICROBE. 2023;4(7):e488
Mucosal immune responses following a fourth SARS-CoV-2 vaccine dose
Bladh O; Marking U; Havervall S; Norin NG; Aguilera K; Hober S; Smed-Soerensen A; Gordon M; Blom K; Aberg M; Klingstrom J; Thalin C
Letter: THE LANCET INFECTIOUS DISEASES. 2023;23(2):150-152
7-month duration of SARS-CoV-2 mucosal immunoglobulin-A responses and protection
Marking U; Bladh O; Havervall S; Svensson J; Greilert-Norin N; Aguilera K; Kihlgren M; Salomonsson A-C; Mansson M; Gallini R; Kriegholm C; Bacchus P; Hober S; Gordon M; Blom K; Smed-Sorensen A; Aberg M; Klingstrom J; Thalin C
Letter: NEW ENGLAND JOURNAL OF MEDICINE. 2022;387(14):1333-1336
Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection
Havervall S; Marking U; Svensson J; Greilert-Norin N; Bacchus P; Nilsson P; Hober S; Gordon M; Blom K; Klingstrom J; Aberg M; Smed-Sorensen A; Thalin C
Letter: EMERGING INFECTIOUS DISEASES. 2022;28(10):2119-2121
Infection Rate of SARS-CoV-2 in Asymptomatic Healthcare Workers, Sweden, June 2022
Blom K; Havervall S; Marking U; Norin NG; Bacchus P; Groenheit R; Brave A; Thalin C; Klingstrom J
Letter: THE LANCET INFECTIOUS DISEASES. 2022;22(7):943-945
Immune responses after omicron infection in triple-vaccinated health-care workers with and without previous SARS-CoV-2 infection
Blom K; Marking U; Havervall S; Norin NG; Gordon M; Garcia M; Tecleab T; Christ W; Forsell M; Phillipson M; Nilsson P; Mangsbo S; Hober S; Aberg M; Klingstrom J; Thalin C
Letter: JOURNAL OF THROMBOSIS AND HAEMOSTASIS. 2022;20(1):267-269
Persistent endotheliopathy in the pathogenesis of long COVID syndrome: Comment from von Meijenfeldt et al.
von Meijenfeldt FA; Havervall S; Adelmeijer J; Thalin C; Lisman T
Letter: THROMBOSIS AND HAEMOSTASIS. 2021;121(12):1668-1669
COVID-19 is Associated with an Acquired Factor XIII Deficiency
von Meijenfeldt FA; Havervall S; Adelmeijer J; Lundstrom A; Magnusson M; Mackman N; Thalin C; Lisman T
Letter: ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY. 2021;41(6):e381-e382
Response by Mackman et al to Letter Regarding Article, "Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report"
Mackman N; Hisada Y; Grover SP; Rosell A; Havervall S; von Meijenfeldt F; Aguilera K; Lisman T; Thalin C
Letter: JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (JAMA). 2021;325(19):2015-2016
Symptoms and Functional Impairment Assessed 8 Months After Mild COVID-19 Among Health Care Workers
Havervall S; Rosell A; Phillipson M; Mangsbo SM; Nilsson P; Hober S; Thalin C
Letter: AMERICAN JOURNAL OF HEMATOLOGY. 2021;96(4):E98-E100
Elevated factor V activity and antigen levels in patients with Covid-19 are related to disease severity and 30-day mortality
von Meijenfeldt FA; Havervall S; Adelmeijer J; Lundstrom A; Magnusson M; Mackman N; Thalin C; Lisman T
Letter: BLOOD ADVANCES. 2021;5(3):756-759
Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge
von Meijenfeldt FA; Havervall S; Adelmeijer J; Lundstrom A; Magnusson M; Mackman N; Thalin C; Lisman T

Employments

Phd Student, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, 2022-2025

Degrees and Education

Degree Of Doctor Of Philosophy, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, 2024

About me

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI